Literature DB >> 33446061

Bioreactors for Vocal Fold Tissue Engineering.

Ana M Gracioso Martins1,2, Andreea Biehl1,2, Daphne Sze1,2, Donald O Freytes1,2.   

Abstract

It is estimated that almost one-third of the United States population will be affected by a vocal fold (VF) disorder during their lifespan. Promising therapies to treat VF injury and scarring are mostly centered on VF tissue engineering strategies such as the injection of engineered biomaterials and cell therapy. VF tissue engineering, however, is a challenging field as the biomechanical properties, structure, and composition of the VF tissue change upon exposure to mechanical stimulation. As a result, the development of long-term VF treatment strategies relies on the characterization of engineered tissues under a controlled mechanical environment. In this review, we highlight the importance of bioreactors as a powerful tool for VF tissue engineering with a focus on the current state of the art of bioreactors designed to mimic phonation in vitro. We discuss the influence of the phonatory environment on the development, function, injury, and healing of the VF tissue and its importance for the development of efficient therapeutic strategies. A concise and comprehensive overview of bioreactor designs, principles, operating parameters, and scalability are presented. An in-depth analysis of VF bioreactor data to date reveals that mechanical stimulation significantly influences cell viability and the expression of proinflammatory and profibrotic genes in vitro. Although the precision and accuracy of bioreactors contribute to generating reliable results, diverse gene expression profiles across the literature suggest that future efforts should focus on the standardization of bioreactor parameters to enable direct comparisons between studies. Impact statement We present a comprehensive review of bioreactors for vocal fold (VF) tissue engineering with a focus on the influence of the phonatory environment on the development, function, injury, and healing of the VFs and the importance of mimicking phonation on engineered VF tissues in vitro. Furthermore, we put forward a strong argument for the continued development of bioreactors in this area with an emphasis on the standardization of bioreactor designs, principles, operating parameters, and oscillatory regimes to enable comparisons between studies.

Entities:  

Keywords:  bioreactor; fibrosis; gene expression; inflammation; lamina propria; vocal fold

Mesh:

Substances:

Year:  2021        PMID: 33446061      PMCID: PMC8892964          DOI: 10.1089/ten.TEB.2020.0285

Source DB:  PubMed          Journal:  Tissue Eng Part B Rev        ISSN: 1937-3368            Impact factor:   6.389


  168 in total

1.  Histopathologic study of human vocal fold mucosa unphonated over a decade.

Authors:  Kiminori Sato; Hirohito Umeno; Takeharu Ono; Tadashi Nakashima
Journal:  Acta Otolaryngol       Date:  2011-09-15       Impact factor: 1.494

2.  Mechanics of human voice production and control.

Authors:  Zhaoyan Zhang
Journal:  J Acoust Soc Am       Date:  2016-10       Impact factor: 1.840

Review 3.  Modulation of Systemic Metabolism by MMP-2: From MMP-2 Deficiency in Mice to MMP-2 Deficiency in Patients.

Authors:  Carlos Fernandez-Patron; Zamaneh Kassiri; Dickson Leung
Journal:  Compr Physiol       Date:  2016-09-15       Impact factor: 9.090

4.  Voice disorders in the general population: prevalence, risk factors, and occupational impact.

Authors:  Nelson Roy; Ray M Merrill; Steven D Gray; Elaine M Smith
Journal:  Laryngoscope       Date:  2005-11       Impact factor: 3.325

5.  Homeostasis of hyaluronic acid in normal and scarred vocal folds.

Authors:  Ichiro Tateya; Tomoko Tateya; Makoto Watanuki; Diane M Bless
Journal:  J Voice       Date:  2014-12-09       Impact factor: 2.009

6.  Matrix crosslinking forces tumor progression by enhancing integrin signaling.

Authors:  Kandice R Levental; Hongmei Yu; Laura Kass; Johnathon N Lakins; Mikala Egeblad; Janine T Erler; Sheri F T Fong; Katalin Csiszar; Amato Giaccia; Wolfgang Weninger; Mitsuo Yamauchi; David L Gasser; Valerie M Weaver
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

7.  Expression of extracellular matrix genes during myocardial recovery from heart failure after left ventricular assist device support.

Authors:  Leanne E Felkin; Enrique Lara-Pezzi; Robert George; Magdi H Yacoub; Emma J Birks; Paul J R Barton
Journal:  J Heart Lung Transplant       Date:  2009-02       Impact factor: 10.247

8.  Vocal fold myofibroblast profile of scarring.

Authors:  Anete Branco; Stephanie M Bartley; Suzanne N King; Marie E Jetté; Susan L Thibeault
Journal:  Laryngoscope       Date:  2015-09-07       Impact factor: 3.325

9.  CCN2/CTGF is required for matrix organization and to protect growth plate chondrocytes from cellular stress.

Authors:  Faith Hall-Glenn; Armen Aivazi; Lusi Akopyan; Jessica R Ong; Ruth R Baxter; Paul D Benya; Roel Goldschmeding; Frans A van Nieuwenhoven; Ernst B Hunziker; Karen M Lyons
Journal:  J Cell Commun Signal       Date:  2013-05-13       Impact factor: 5.782

Review 10.  Recent advances in stem cell therapeutics and tissue engineering strategies.

Authors:  Seong Gyu Kwon; Yang Woo Kwon; Tae Wook Lee; Gyu Tae Park; Jae Ho Kim
Journal:  Biomater Res       Date:  2018-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.